IgA autoimmune haemolytic anaemia in a pregnant woman.
Year: 2014
Type: article
Abstract: Dear Sir,
Autoimmune haemolytic anaemia (AIHA) is a clinical condition caused by IgG, IgM or IgA antibodies to red blood cells. This condition affects 1–3 per 100,000 individuals per year1. Although IgA antibodies have been reported in 14% of cases of warm AIHA, they are mostly associated with IgG and/or IgM antibodies, while warm AIHA due exclusively to IgA antibodies is rare2. Several methods have been developed for the detection of these auto-antibodies. The direct antiglobulin test (DAT) by the conventional tube technique (CTT) is the gold standard.
About 12% of AIHA patients show a negative CTT-DAT, possibly caused by the level of RBC-bound immunoglobulin being below the threshold, the presence of low-affinity IgG that washes off the RBC during the CTT-DAT washing phase and RBC-bound IgA or IgM not detected by routine antiglobulin reagents. In such cases, it is important to use additional tests to characterise the autoantibody and to confirm the diagnosis. We report an unusual case of IgA-AIHA in a pregnant woman not detected by CTT-DAT.
A 32-year old woman in the 21st week of gestation of her second pregnancy was admitted to our hospital because of asthenia, headache and anaemia. The day before, the patient had received two units of RBC in another hospital. The patient’s history was negative for chronic anaemia, medication use and infectious diseases. Laboratory results were as follows: haemoglobin 6.2 g/dL, reticulocytes 340×109/L, white blood cells 157×109/L, haptoglobin <6 mg/dL, lactate dehydrogenase 672 U/L, and indirect bilirubin 2.18 mg/dL. These data supported the diagnosis of haemolytic anaemia.
The patient’s blood type was O Rh positive: CcDee; K−k+; Jk(a+b−); Fy(a−b+); M+N−S+s−. The CTT-DAT, performed with polyspecific anti-human globulin, monospecific anti-IgG and anti-C3 antisera from three manufacturers (Gamma Biologicals, Houston, TX, USA; Ortho-Clinical Diagnostics, Raritan, NJ, USA; Immucor Inc. Norcross, GA, USA), and anti-IgA and IgM antisera from one manufacturer (Immucor), was negative. The DAT performed by solid-phase (Capture Select, Immucor) and the mitogen-stimulated DAT3 were negative, while the DAT performed with a gel column test (BIORAD, Cressier sur Morat, Swiss) was positive (score 2+) only with anti-IgA antiglobulin. The autoantibodies eluted from the patient’s RBC (Elu-Kit II, Gamma) showed anti-e specificity. Irregular antibody screening and identification were performed by the indirect antiglobulin test in a microcolumn card (Ortho) and tube test with additive polyethylene glycol (PeG, Gamma) using anti-IgG and anti-IgA antiglobulin reagents. Free antibodies were not detected in the serum.
The data led to the diagnosis of IgA-AIHA. An ultrasound of the foetus showed no abnormalities. The patient was treated with intravenous corticosteroids from day 10 to 113, with a starting daily dose of 80 mg/kg for 5 days, followed by tapering to 2.5 mg from day 83 to 113. Moreover, from day 17 to 21 the patient received 400 mg/kg/die of intravenous immunoglobulins to reduce the risk of complications due to the high steroid dosage in pregnancy (preterm premature rupture of the membranes, gestational diabetes and hypertension).
The haemoglobin level began to rise after the administration of steroids and these treatments improved the patient’s condition. The laboratory data are reported in Figures 1 and and2.2. One month after admission the patient was discharged. At the end of gestation she delivered a healthy male neonate. A maternal DAT with anti-IgA reagent was still weakly reactive with the gel column test (1+) and free antibodies were not detected in the serum with anti-IgG and anti-IgA antiglobulin reagents.
Figure 1
Haemoglobin (____), reticulocytes (...), haptoglobin (-------) and DAT (↓).
Figure 2
Lactate dehydrogenase (...) and bilirubin (____).
AIHA can be a very severe disease, if not promptly detected and correctly treated. However, in pregnancy the presence of maternal autoantibodies may have little relevance for the foetus1. Despite this, the correct identification of the presence of maternal autoantibodies is important for the differential diagnosis from several autoimmune conditions. For this reason, the Immunohaematology Laboratory must ensure that the techniques used for the patient’s workup include several methods with appropriate sensitivity, such as a monocyte monolayer assay, eluate concentration, the direct Polybrene test, the direct polyethylene glycol test, solid-phase, gel column test, DAT using cold washes and the mitogen-stimulated DAT. In rare cases, warm AIHA can be associated with IgA or IgM autoantibodies without IgG being present. The presence of more than one type of antibodies on RBC, even when undetected by agglutination methods, can be a major cause of haemolysis along with other factors, such as the quantity of bound IgG, IgG subclass pattern, and complement2. Recently, Chadebech et al.4 reported that trapping and sequestration of agglutinated RBC in the spleen are the principal pathogenic mechanisms of IgA-AIHA and that “elucidation of the mechanism responsible for the immune destruction of RBCs would help to guide decisions concerning the choice of first-line treatment”. Therefore, the autoantibody class, including IgA, and possibly the autoantibody specificity should be determined rapidly in order to provide AIHA patients with appropriate treatment (such as splenectomy).
IgA AHIA is quite rare, with reported incidences ranging from 0.2 to 2.7%2- Its incidence is, however, likely to be underestimated, because the CTT-DAT may often be falsely negative. A threshold of 150–400 IgG molecules/RBC is required to generate agglutination sufficient for a positive result in the CTT-DAT. Therefore, in cases with <150 IgG molecules/RBC, or in cases in which a warm IgM or IgA antibody is mediating the process, the CTT-DAT is unlikely to elucidate the diagnosis.
Our findings confirm that the gel column test is more suitable and more sensitive than CTT-DAT for the identification of RBC-bound IgA5. In conclusion, we recommend performing the CTT-DAT with monospecific antiglobulin anti-IgG, anti-IgM, anti-IgA, anti-C3d antisera and, before performing more complex procedures, using the gel column test, which is more sensitive, in patients in whom the suspicion of AIHA is strong and who have an apparently negative CTT-DAT.
Source: PubMed
DOI: 10.2450/2014.0315-13
Authors: Maria A Villa, Norma N Fantini, Nicoletta Revelli, Barbara Acaia, Cinzia Paccapelo, Maria C Manera, Maurizio Marconi
Language: Italian
Topic: Blood groups and transfusion
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W8675465
